|
|
Volumn 19, Issue 11, 1996, Pages 1311-1315
|
|
American Diabetes Association Annual Meeting 1996: The etiology of type II diabetes, obesity, and the treatment of type II diabetes
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
2,4 THIAZOLIDINEDIONE DERIVATIVE;
ADRENERGIC RECEPTOR STIMULATING AGENT;
BROMOCRIPTINE;
CAFFEINE;
CARBOXYMETHYLCELLULOSE;
CHROMIUM PICOLINATE;
CIMETIDINE;
DEXFENFLURAMINE;
DOPAMINE RECEPTOR STIMULATING AGENT;
EPHEDRINE;
FENFLURAMINE;
FLUOXETINE;
GLIBENCLAMIDE;
GLICLAZIDE;
ISOPHANE INSULIN;
MAZINDOL;
METFORMIN;
MIGLITOL;
ORAL ANTIDIABETIC AGENT;
PHENTERMINE;
PHENYLPROPANOLAMINE;
ROSIGLITAZONE;
SIBUTRAMINE;
SULFONYLUREA DERIVATIVE;
TAGATOSE;
TETRAHYDROLIPSTATIN;
TROGLITAZONE;
TRYPTOPHAN;
UNINDEXED DRUG;
YOHIMBINE;
CLINICAL TRIAL;
CONFERENCE PAPER;
COST BENEFIT ANALYSIS;
DIABETES CONTROL;
DIABETES MELLITUS;
EXERCISE;
GENE THERAPY;
HUMAN;
IMPAIRED GLUCOSE TOLERANCE;
INSULIN RESISTANCE;
INSULIN TREATMENT;
LIFESTYLE;
NON INSULIN DEPENDENT DIABETES MELLITUS;
OBESITY;
ORAL DRUG ADMINISTRATION;
OVARY POLYCYSTIC DISEASE;
WEIGHT REDUCTION;
|
|
EID: 0029905094
PISSN: 01495992
EISSN: None
Source Type: Journal
DOI: 10.2337/diacare.19.11.1311 Document Type: Conference Paper |
|
Times cited : (11)
|
|
References (0)
|